Pancreatic Cancer Research

ResearcherYonsei UniversityActive in the last 2 years

Jong‐Baeck Lim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0419-0422; OpenAlex author ID A5005354568. Sources: OpenAlex.

Their work

Papers
7 (first author 3, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. REG4 serves as a prognostic biomarker for pancreatic cancer with long-standing diabetes mellitus by modulating chemoresistance. Last author DOI 10.1016/j.tranon.2026.102888↗
  2. The role of Jagged1 as a dynamic switch of cancer cell plasticity in PDAC assembloids. Last author DOI 10.7150/thno.71364↗
  3. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells. Last author DOI 10.1016/j.canlet.2020.10.012↗
  4. Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma. First author DOI 10.1186/1479-5876-12-102↗
  5. Clinical implications and diagnostic usefulness of correlation between soluble major histocompatibility complex class I chain-related molecule a and protumorig… Last author DOI 10.1002/cncr.27669↗
  6. Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma. First author DOI 10.1111/j.1349-7006.2012.02358.x↗
  7. Clinical significance of serum levels of immune-associated molecules, uric acid and soluble MHC class I chain-related molecules A and B, as diagnostic tumor ma… First author DOI 10.1111/j.1349-7006.2011.01989.x↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sung Ill Jang · 3 shared papers, 2021–2026 · strength 0.58
  2. Jae-Il Choi · 2 shared papers, 2021–2022 · strength 0.32
  3. Joon Seong Park · 2 shared papers, 2021–2022 · strength 0.32
  4. Jae-Il Choi · 1 shared paper, 2026 · strength 0.26
  5. Jae Hee Cho · 1 shared paper, 2022 · strength 0.17
  6. Hye Won Chung · 3 shared papers, 2011–2013 · strength 0.15
  7. Hye Jin Chung · 1 shared paper, 2014 · strength 0.09
  8. Si Young Song · 1 shared paper, 2012 · strength 0.04
  9. Kyong Joo Lee · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.